Product image of Kenalog (Triamcinolone Acetonide) supplied by GNH India

Kenalog

Active Ingredient:
Triamcinolone Acetonide
Origin:
EU

Kenalog (Triamcinolone Acetonide)

Triamcinolone acetonide, the active ingredient in Kenalog, is a corticosteroid presented as a sterile injectable solution for intra‑articular, intralesional and intramuscular use. It belongs to the anti‑inflammatory and immunosuppressant therapeutic class and is employed to reduce inflammation in joint disorders and dermatologic lesions in adult patients.

GNH India supplies Kenalog as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Kenalog is used to treat inflammatory and immune‑mediated conditions affecting joints, skin and systemic sites.
  • Osteoarthritis: reduces joint inflammation and pain when injected intra‑articularly.
  • Rheumatoid arthritis: decreases synovial inflammation and limits joint damage via intra‑articular injection.
  • Keloids and hypertrophic scars: softens scar tissue and limits excessive collagen formation when given intralesionally.
  • Dermatologic inflammatory conditions (e.g., psoriasis, eczema): alleviates redness, swelling and itching through intralesional injection.
  • Systemic inflammatory disorders: provides broad anti‑inflammatory effect when administered intramuscularly.

How It Works

  • Triamcinolone acetonide binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. This interaction suppresses the synthesis of pro‑inflammatory cytokines, chemokines and adhesion molecules while enhancing anti‑inflammatory protein expression, leading to reduced leukocyte migration, vascular permeability and immune activation at the site of administration.

Side Effects

Kenalog may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Injection site pain: transient discomfort at the injection area.
  • Localized swelling or bruising: mild tissue reaction.
  • Transient hyperglycemia: temporary rise in blood glucose.
  • Headache: mild to moderate intensity.

Serious or Rare Side Effects

  • Adrenal suppression: reduced endogenous cortisol production.
  • Severe infection: increased susceptibility to bacterial or fungal infections.
  • Allergic reaction (anaphylaxis): rapid onset of hives, breathing difficulty.
  • Cushingoid appearance: facial rounding and weight gain with prolonged use.

Precautions & Warnings

  • Before using Kenalog, clinicians should consider several precautionary measures to ensure safe therapy.
  • Assess infection risk: avoid use in active systemic infections.
  • Monitor blood glucose: patients with diabetes may experience hyperglycemia.
  • Evaluate adrenal function: prolonged therapy can suppress the hypothalamic‑pituitary‑adrenal axis.
  • Use caution in glaucoma: corticosteroids may increase intra‑ocular pressure.
  • Store at ambient temperature: keep in original packaging, protect from moisture and light.

Avoid Interactions

Kenalog can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Systemic CYP3A4 inhibitors (e.g., ketoconazole): may increase steroid levels and risk of toxicity.
  • Live vaccines: immunosuppression can reduce vaccine effectiveness and increase infection risk.
  • Systemic anticoagulants (e.g., warfarin): heightened risk of bleeding.

Moderate Interactions (Monitor Closely)

  • NSAIDs: combined use may increase gastrointestinal ulcer risk.
  • Antidiabetic agents: corticosteroid‑induced hyperglycemia may require dose adjustment.

Frequently Asked Questions

Kenalog (triamcinolone acetonide) is administered by injection for several inflammatory conditions. It is used intra‑articularly for osteoarthritis and rheumatoid arthritis, intralesionally for keloids, hypertrophic scars and other dermatologic inflammatory diseases, and intramuscularly when a systemic anti‑inflammatory effect is required.

The active molecule binds to intracellular glucocorticoid receptors, and the resulting complex moves into the cell nucleus. There it alters gene transcription, decreasing production of pro‑inflammatory cytokines and increasing anti‑inflammatory proteins, which together dampen immune cell activity and reduce swelling and pain.

The dose of Kenalog is individualized by the prescribing clinician based on the specific indication, route of administration, patient weight, age and clinical response. No standard dosing regimen is provided here; the prescriber determines the appropriate amount and frequency.

Safety data for triamcinolone acetonide in pregnancy and lactation are limited. The drug should only be used when the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by the treating physician after evaluating the clinical situation.

To request Kenalog, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.

Kenalog (triamcinolone acetonide) is a medium‑ to high‑potency glucocorticoid with a longer duration of action than hydrocortisone but generally less potent than dexamethasone. Its pharmacokinetic profile makes it suitable for intra‑articular and intralesional use, offering strong anti‑inflammatory effects while allowing clinicians to tailor dosing intervals.

Kenalog should be stored at ambient temperature, preferably below 25 °C. Keep the vials in their original packaging, protect them from moisture and direct light, and avoid freezing. Follow any additional handling instructions supplied with the product.

Kenalog is supplied as a sterile injectable solution. It can be given intra‑articularly into a joint space, intralesionally into skin lesions, or intramuscularly for systemic effect. Administration is performed by a qualified health‑care professional using aseptic technique.

The most serious adverse events include adrenal suppression, which can lead to cortisol deficiency, severe or opportunistic infections due to immunosuppression, and rare systemic allergic reactions such as anaphylaxis. Patients should be monitored for signs of these conditions during and after therapy.

Kenalog is contraindicated in patients with known hypersensitivity to triamcinolone acetonide or any formulation components, in those with active systemic infections, and in individuals receiving live vaccines. Caution is also advised for patients with uncontrolled diabetes, glaucoma, or severe osteoporosis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Triamcinolone Acetonide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT